Related Experiment Videos
[Depression after cerebrovascular injury. Review and differentiation from other psychiatric complications]
S Frühwald1, H Löffler, U Baumhackl
1Neurologische Abteilung, KH St. Pölten. stefan.fruehwald@univie.ac.at
Insights
Post-stroke depression affects 20-50% of patients, leading to poor outcomes and reduced quality of life. This review highlights the need for better treatment strategies for this common psychiatric complication after stroke.
Area of Science:
- Neurology
- Psychiatry
- Clinical Medicine
Context:
- Cerebrovascular injury, commonly known as stroke, frequently leads to psychiatric complications.
- Post-stroke psychiatric disorders, particularly depression, are prevalent but often overlooked.
- Existing research on post-stroke psychiatric conditions has yielded limited and sometimes contradictory findings.
Purpose:
- To review the current literature on psychiatric disorders following stroke.
- To concentrate on the specific challenges and characteristics of Post-stroke Depression (PSD).
- To critically evaluate existing therapeutic interventions and provide recommendations.
Summary:
- Post-stroke Depression (PSD) affects an estimated 20-50% of stroke survivors.
- PSD significantly increases mortality, hinders rehabilitation, and diminishes long-term quality of life.
- Despite its high prevalence and severe consequences, PSD often remains untreated, with limited drug efficacy studied in controlled trials.
Impact:
- Highlights the significant impact of PSD on patient recovery and survival.
- Underscores the urgent need for effective diagnostic and therapeutic strategies for PSD.
- Provides a critical overview of current knowledge and treatment options for clinicians and researchers.
Abstract:
In spite of the high incidence and prevalence of psychiatric complications after cerebrovascular injury few results have remained uncontradicted so far. This article focuses on the variety of psychiatric disorders after stroke reviewing recent literature and concentrating in particular on Post-stroke Depression. The prevalence of depressive disorders following stroke is assessed between 20 and 50%. Serious consequences for post-stroke depressed subjects are their increased mortality, poor rehabilitation outcome and long-term affected quality of life. Nevertheless, depressive disorders following stroke usually remain untreated. To this date the effectiveness of only a few drugs has been studied in controlled clinical trials (Nortriptylin, Citalopram, Imipramin, Mianserin). Besides describing clinical presentation, epidemiology, pathogenesis and consequences of post-stroke depressive disorders for the patient different authors' statements are listed and critically commented. Finally recommendations concerning therapeutic intervention are mentioned.